Hudson Bay Capital Management
RETA

Hudson Bay Capital Management’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History

Hudson Bay Capital Management’s Portfolio RETA Stock Details RETA Fund Activity
Upgrade to unlock
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
2023
Q2 		$4.08M Buy
2023
Q1 		– Sell
2022
Q4 		$760K Buy
2021
Q2 		– Sell
2021
Q1 		$619K Buy